-+ 0.00%
-+ 0.00%
-+ 0.00%

Endovia Health Sciences narrows FY26 H1 operating loss 64% to $4 million

PUBT·08/20/2026 13:02:20
Listen to the news
Endovia Health Sciences narrows FY26 H1 operating loss 64% to $4 million
  • Endovia Health Sciences (formerly Splash Beverage) reported a continuing-operations loss of about $4 million for the six months ended June 30, 2026.
  • That loss narrowed by about $7 million, a 64% improvement from the year-earlier period, on cost-reduction initiatives implemented over six months.
  • Management highlighted continued cuts to corporate overhead, simplified operating structure, and efforts to unwind legacy obligations.
  • Post-quarter, the group secured an exclusive global CannEpil license, expanded it to veterinary applications, and partnered with Lupvindol on FDA-CVM development.
  • A corporate name and NYSE American ticker change to Endovia Health Sciences is expected to take effect Aug. 24, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Endovia Health Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200900PRIMZONEFULLFEED9813452) on August 20, 2026, and is solely responsible for the information contained therein.